A method of sequential extraction of /3-glucuronidase-hydrolyzed urine, which permits the assessment of alternative pathways of corticosteroid excretion, was employedto study urine samplesfrom normal subjects and from patients with hepatic cirrhosis. In patients with hepatic cirrhosis there is a decrease in the excretion ef methylene dichloride-soluble 17-hydroxycorticosteroids; this decrease is due to significantly lower levels of tetrahydrocortisone, with moderately low levels of tetrahydrocortisol. A significant increase was observed in the levels of 17-OH,20,21-glycols, confined mainly to cortols in the urine of patients with cirrhosis; a less marked increasein this fraction was also observed in patients with fatty metamorphosis of the liver. Urinary 17-ketosteroids were decreased in patients with hepatic cirrhosis.The intravenous infusion of adrenocorticotropin to normal subjects was followed by increased 17-hydroxycorticosteroidsin all solvent fractions of the urine. In patients with hepatic cirrhosis similarly treated, there was no significant rise in the level of 17-hydroxycorticosteroidsextracted with methylene dichloride, but significant increasesin polar 17-hydroxycorticosteroidswere found.
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Materials and Methods
Terminology
The following abbreviations are used in this paper: 
ChemicalMethods:Extraction
The urinary corticosteroids were quantitated by the method of sequential extraction of $-glucuronidase-hydrolyzed urine
In the present study the adjustment of the enzyme-hydrolyzed urine to pH 1.0 was omitted.
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-a by employing Sephadex U-iS, and quantitating the estrogens fluorometrically.
In some studies individual compounds were identified after paper chromatography, sulfuric acid chromogen spectrums, and selective oxidation and reduction studies (5, 7, 12).
Results
Corficosieroids in Solvent Fractions of Urine from Normal Subjects and Patients with Liver Disease
The data presented in Total estrogens are somewhat higher than normal in patients with cirrhosis.
The data in Table 2 
Urinary Corticosferoids Following ACTH Infusion
The data of Fig. 1 
Urinary Corticosferoids Following Infusion of Metyrapone (SU 4885)
In this study the adrenal li-hydroxylase inhibitor metyrapone (SU 4885) was given I.V., and two postinfusion 24-hr. urine samples were obtained from each patient. The data of Fig. 2 reveal that in the normal ,0-.
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